JP2014515040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014515040A5 JP2014515040A5 JP2014510929A JP2014510929A JP2014515040A5 JP 2014515040 A5 JP2014515040 A5 JP 2014515040A5 JP 2014510929 A JP2014510929 A JP 2014510929A JP 2014510929 A JP2014510929 A JP 2014510929A JP 2014515040 A5 JP2014515040 A5 JP 2014515040A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- independently
- drug
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C**C(N)=C(***NC)I Chemical compound C**C(N)=C(***NC)I 0.000 description 3
- PZILMLQXTGDJCM-UHFFFAOYSA-N C(C1)NCCN1c1nnc(N2CCNCC2)nn1 Chemical compound C(C1)NCCN1c1nnc(N2CCNCC2)nn1 PZILMLQXTGDJCM-UHFFFAOYSA-N 0.000 description 1
- XSWILQCWFQOKIE-UHFFFAOYSA-N C1CC(c2nnc(C3NCCCC3)nn2)NCC1 Chemical compound C1CC(c2nnc(C3NCCCC3)nn2)NCC1 XSWILQCWFQOKIE-UHFFFAOYSA-N 0.000 description 1
- ITWARJUHZJXKNM-UHFFFAOYSA-N CC(C1)C=C(C)C=C1NC(OC1C=CCCCCC1)=O Chemical compound CC(C1)C=C(C)C=C1NC(OC1C=CCCCCC1)=O ITWARJUHZJXKNM-UHFFFAOYSA-N 0.000 description 1
- XLZCIYOGIKMDSG-UHFFFAOYSA-N CC(C1C2CCCCCC1)=NN=C2c1ccccn1 Chemical compound CC(C1C2CCCCCC1)=NN=C2c1ccccn1 XLZCIYOGIKMDSG-UHFFFAOYSA-N 0.000 description 1
- NGMHTEDSSHAFGW-UHFFFAOYSA-N Cc1c[nH]c(-c2nnc(-c3nc(C)c[nH]3)nn2)n1 Chemical compound Cc1c[nH]c(-c2nnc(-c3nc(C)c[nH]3)nn2)n1 NGMHTEDSSHAFGW-UHFFFAOYSA-N 0.000 description 1
- ASUZTNLCAHONDF-UHFFFAOYSA-N Cc1nnc(-c2ccccn2)nn1 Chemical compound Cc1nnc(-c2ccccn2)nn1 ASUZTNLCAHONDF-UHFFFAOYSA-N 0.000 description 1
- PMMSDMUGUYODMC-UHFFFAOYSA-N NCc1nnc(CN)nn1 Chemical compound NCc1nnc(CN)nn1 PMMSDMUGUYODMC-UHFFFAOYSA-N 0.000 description 1
- FOJXFFILELMRKJ-UHFFFAOYSA-N c1cnc(-c2nnc(-c3ncc[nH]3)nn2)[nH]1 Chemical compound c1cnc(-c2nnc(-c3ncc[nH]3)nn2)[nH]1 FOJXFFILELMRKJ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11166241.7 | 2011-05-16 | ||
| EP11166241 | 2011-05-16 | ||
| EP11166942.0 | 2011-05-20 | ||
| EP11166942 | 2011-05-20 | ||
| US201161515432P | 2011-08-05 | 2011-08-05 | |
| US201161515458P | 2011-08-05 | 2011-08-05 | |
| EP11176741.4 | 2011-08-05 | ||
| EP11176741 | 2011-08-05 | ||
| EP11176736 | 2011-08-05 | ||
| US61/515,458 | 2011-08-05 | ||
| EP11176736.4 | 2011-08-05 | ||
| US61/515,432 | 2011-08-05 | ||
| EP11192577 | 2011-12-08 | ||
| EP11192577.2 | 2011-12-08 | ||
| EP11192572 | 2011-12-08 | ||
| EP11192572.3 | 2011-12-08 | ||
| PCT/IB2012/052446 WO2012156919A1 (en) | 2011-05-16 | 2012-05-16 | Bio-orthogonal drug activation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016161617A Division JP2017014262A (ja) | 2011-05-16 | 2016-08-22 | 生体直交型薬物活性化 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014515040A JP2014515040A (ja) | 2014-06-26 |
| JP2014515040A5 true JP2014515040A5 (cg-RX-API-DMAC7.html) | 2016-03-03 |
| JP5993940B2 JP5993940B2 (ja) | 2016-09-21 |
Family
ID=47176369
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014510928A Active JP6215194B2 (ja) | 2011-05-16 | 2012-05-16 | 生体直交型薬物活性化 |
| JP2014510929A Active JP5993940B2 (ja) | 2011-05-16 | 2012-05-16 | 生体直交型薬物活性化 |
| JP2014510930A Active JP6482273B2 (ja) | 2011-05-16 | 2012-05-16 | 生体直交型薬物活性化 |
| JP2016161617A Ceased JP2017014262A (ja) | 2011-05-16 | 2016-08-22 | 生体直交型薬物活性化 |
| JP2018000737A Active JP6608467B2 (ja) | 2011-05-16 | 2018-01-05 | 生体直交型薬物活性化 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014510928A Active JP6215194B2 (ja) | 2011-05-16 | 2012-05-16 | 生体直交型薬物活性化 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014510930A Active JP6482273B2 (ja) | 2011-05-16 | 2012-05-16 | 生体直交型薬物活性化 |
| JP2016161617A Ceased JP2017014262A (ja) | 2011-05-16 | 2016-08-22 | 生体直交型薬物活性化 |
| JP2018000737A Active JP6608467B2 (ja) | 2011-05-16 | 2018-01-05 | 生体直交型薬物活性化 |
Country Status (9)
| Country | Link |
|---|---|
| US (8) | US20160151505A1 (cg-RX-API-DMAC7.html) |
| EP (4) | EP2709666B1 (cg-RX-API-DMAC7.html) |
| JP (5) | JP6215194B2 (cg-RX-API-DMAC7.html) |
| CN (4) | CN108524510A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2012257418B2 (cg-RX-API-DMAC7.html) |
| CA (3) | CA2836338C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2709667T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2920373T3 (cg-RX-API-DMAC7.html) |
| WO (3) | WO2012156918A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2836338C (en) * | 2011-05-16 | 2022-05-03 | Koninklijke Philips N.V. | Tetrazine derivatives used in bio-orthogonal drug activation |
| US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| WO2014028537A1 (en) | 2012-08-14 | 2014-02-20 | 10X Technologies, Inc. | Microcapsule compositions and methods |
| US10584381B2 (en) | 2012-08-14 | 2020-03-10 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| WO2014065860A1 (en) | 2012-10-24 | 2014-05-01 | The General Hospital Corporation | Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions |
| WO2014081299A1 (en) * | 2012-11-22 | 2014-05-30 | Tagworks Pharmaceuticals B.V. | Activatable liposomes |
| WO2014081300A1 (en) * | 2012-11-22 | 2014-05-30 | Tagworks Pharmaceuticals B.V. | Channel protein activatable liposomes |
| EP4245744A3 (en) | 2012-11-22 | 2024-05-01 | Tagworks Pharmaceuticals B.V. | Chemically cleavable group |
| US20150297741A1 (en) * | 2012-11-22 | 2015-10-22 | Tagworks Pharmaceuticals B.V. | Bio-orthogonal drug activation |
| US9580553B2 (en) | 2012-12-07 | 2017-02-28 | University Of Washington Through Its Center For Commercialization | Thermally-activated self-immolative materials |
| US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
| AU2014214682B2 (en) | 2013-02-08 | 2018-07-26 | 10X Genomics, Inc. | Polynucleotide barcode generation |
| PT3611180T (pt) | 2013-03-15 | 2022-03-15 | Biomolecular Holdings Llc | Imunoglobulina híbrida que contém uma ligação não peptídica |
| MY183572A (en) | 2013-03-15 | 2021-02-26 | Regeneron Pharma | Biologically active molecules, conjugates thereof, and therapeutic uses |
| US20150087043A1 (en) * | 2013-04-11 | 2015-03-26 | Coferon, Inc | Monomers capable of multimerizing in an aqueous solution that employ bioorthogonal chemistries, and methods of using same |
| WO2014205126A1 (en) | 2013-06-19 | 2014-12-24 | The Regents Of The University Of California | Chemical structures for localized delivery of therapeutic agents |
| CN105530942B (zh) | 2013-08-26 | 2019-10-11 | 瑞泽恩制药公司 | 一种包含大环内酯类非对映体的药物组合物、其制备方法和用途 |
| KR20250051130A (ko) | 2013-09-25 | 2025-04-16 | 싸이톰스 테라퓨틱스, 인크. | 매트릭스 메탈로프로테이나제 기질 및 다른 절단성 모이어티 및 이의 사용 방법 |
| JP6835586B2 (ja) * | 2014-01-31 | 2021-02-24 | シトムクス セラピューティクス，インコーポレイティド | マトリプターゼ及びｕ‐プラスミノーゲン活性化因子の基質及び他の切断可能部分、並びにその使用方法 |
| ES2880468T3 (es) | 2014-03-14 | 2021-11-24 | Univ California | Conjugados de TCO y métodos para el suministro de agentes terapéuticos |
| AU2015229186B2 (en) * | 2014-03-14 | 2021-01-28 | Biomolecular Holdings Llc | Hybrid immunoglobulin containing non-peptidyl linkage |
| US20170119892A1 (en) * | 2014-04-04 | 2017-05-04 | President And Fellows Of Harvard College | Refillable drug delivery devices and methods of use thereof |
| MX2016016902A (es) | 2014-06-26 | 2017-03-27 | 10X Genomics Inc | Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas. |
| US12312640B2 (en) | 2014-06-26 | 2025-05-27 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
| CA2953371C (en) | 2014-06-30 | 2021-08-24 | Tarveda Therapeutics, Inc. | Targeted conjugates and particles and formulations thereof |
| WO2016025480A1 (en) * | 2014-08-11 | 2016-02-18 | The General Hospital Corporation | Cyclooctenes for bioorthogonol reactions |
| CN104356110B (zh) * | 2014-11-19 | 2018-01-23 | 西北大学 | 一种硫诱导3,6‑芳香杂环不对称取代‑1,2,4,5‑四嗪化合物及其合成方法 |
| MA41374A (fr) | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci |
| MX386328B (es) | 2015-03-27 | 2025-03-18 | Regeneron Pharma | Derivados de maitansinoide, conjugados de los mismos, y metodos de uso. |
| US20160331852A1 (en) * | 2015-05-11 | 2016-11-17 | Memorial Sloan Kettering Cancer Center | Radioligands for pretargeted pet imaging and methods of their therapeutic use |
| US10421756B2 (en) | 2015-07-06 | 2019-09-24 | Rodin Therapeutics, Inc. | Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase |
| US20180194769A1 (en) | 2015-07-06 | 2018-07-12 | Rodin Therapeutics, Inc. | Hetero-halo inhibitors of histone deacetylase |
| US10828373B2 (en) | 2015-09-10 | 2020-11-10 | Tambo, Inc. | Bioorthogonal compositions |
| GB201516480D0 (en) | 2015-09-17 | 2015-11-04 | Univ Edinburgh | Tetrazine as a trigger to release caged cargo |
| EP3153155B1 (en) * | 2015-10-08 | 2021-03-03 | President and Fellows of Harvard College | Refillable drug delivery devices and methods of use thereof |
| CA3001712A1 (en) | 2015-10-28 | 2017-05-04 | Tarveda Therapeutics, Inc. | Sstr-targeted conjugates and particles and formulations thereof |
| US10875840B2 (en) * | 2015-12-15 | 2020-12-29 | University Of Delaware | Methods for inducing bioorthogonal reactivity |
| MX390630B (es) | 2016-01-25 | 2025-03-21 | Regeneron Pharma | Derivados de maitansinoide, conjugados de los mismos y metodos de uso. |
| US11690825B2 (en) | 2016-03-09 | 2023-07-04 | Board Of Regents, The University Of Texas System | 20-HETE receptor (GPR75) antagonists and methods of use |
| EP3444239B1 (en) * | 2016-04-06 | 2020-11-04 | Sumitomo Chemical Company, Limited | Heterocyclic compounds useful for controlling arthropods |
| WO2018004338A1 (en) | 2016-06-27 | 2018-01-04 | Tagworks Pharmaceuticals B.V. | Cleavable tetrazine used in bio-orthogonal drug activation |
| HUE057849T2 (hu) | 2017-01-11 | 2022-06-28 | Alkermes Inc | Hiszton deacetiláz biciklusos gátlói |
| EP3385779A1 (en) * | 2017-04-05 | 2018-10-10 | Koninklijke Philips N.V. | Multi-view display device and method |
| ES2983582T3 (es) | 2017-04-07 | 2024-10-23 | Tambo Inc | Composiciones bioortogonales |
| CN107281204A (zh) * | 2017-05-04 | 2017-10-24 | 北京大学 | 一种非对称的1，2，4，5‑四嗪分子的应用 |
| US11560384B2 (en) | 2017-05-04 | 2023-01-24 | University Of Utah Research Foundation | Benzonorbornadiene derivatives and reactions thereof |
| US11559494B2 (en) | 2017-07-14 | 2023-01-24 | The Penn State Research Foundation | Compositions and methods for targeted delivery of therapeutic and/or diagnostic species |
| HUE058799T2 (hu) | 2017-08-07 | 2022-09-28 | Alkermes Inc | Hiszton-deacetiláz biciklusos inhibitorai |
| US10837047B2 (en) * | 2017-10-04 | 2020-11-17 | 10X Genomics, Inc. | Compositions, methods, and systems for bead formation using improved polymers |
| US10590244B2 (en) | 2017-10-04 | 2020-03-17 | 10X Genomics, Inc. | Compositions, methods, and systems for bead formation using improved polymers |
| US11607458B2 (en) | 2017-10-25 | 2023-03-21 | Georgia State University Research Foundation, Inc. | Enrichment-triggered chemical delivery system |
| SG11201913654QA (en) | 2017-11-15 | 2020-01-30 | 10X Genomics Inc | Functionalized gel beads |
| US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
| CN120365276A (zh) * | 2018-04-11 | 2025-07-25 | 透明医药有限公司 | 靶向化合物及其生产方法 |
| DK3788032T3 (da) * | 2018-05-04 | 2024-04-15 | Tagworks Pharmaceuticals B V | Forbindelser omfattende en linker til øgning af transcyklooctenstabilitet |
| AU2019262520B2 (en) | 2018-05-04 | 2025-07-10 | Tagworks Pharmaceuticals B.V. | Tetrazines for high click conjugation yield in vivo and high click release yield |
| WO2019231016A1 (ko) | 2018-05-31 | 2019-12-05 | (주)스파크바이오파마 | 신규한 형광체-테트라진 화합물 및 이의 용도 |
| KR102011772B1 (ko) * | 2018-05-31 | 2019-08-19 | (주)스파크바이오파마 | 신규한 형광체-테트라진 화합물 및 이의 용도 |
| WO2020061101A1 (en) | 2018-09-18 | 2020-03-26 | Nikang Therapeutics, Inc. | Tri-substituted heteroaryl derivatives as src homology-2 phosphatase inhibitors |
| JP7650228B2 (ja) | 2018-10-10 | 2025-03-24 | タンボ・インコーポレイテッド | 官能化シクロオクテンを調製するためのプロセス |
| EP3890764A2 (en) | 2018-12-06 | 2021-10-13 | CytomX Therapeutics, Inc. | Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof |
| WO2020123882A1 (en) * | 2018-12-12 | 2020-06-18 | The General Hospital Corporation | Prodrugs with a tridentate self-immolative linker |
| CN112010817A (zh) * | 2019-05-31 | 2020-12-01 | 四川大学华西医院 | 一种制备四嗪类化合物的方法及其应用 |
| CA3143925A1 (en) * | 2019-06-17 | 2020-12-24 | Tagworks Pharmaceuticals B.V. | Compounds for fast and efficient click release |
| IL289095A (en) | 2019-06-17 | 2022-02-01 | Tagworks Pharmaceuticals B V | Activating components to cleave labels from biomolecules in vivo |
| IL289094A (en) * | 2019-06-17 | 2022-02-01 | Tagworks Pharmaceuticals B V | Tetrazines for increasing the speed and yield of the "click release" reaction |
| CN113321702B (zh) * | 2020-02-28 | 2022-08-05 | 国家纳米科学中心 | 一种单甲基澳瑞他汀f甲酯前药及其制备方法和应用 |
| CN113321698B (zh) * | 2020-02-28 | 2022-08-23 | 国家纳米科学中心 | 一种单甲基澳瑞他汀e前药及其制备方法和应用 |
| CN113354657B (zh) * | 2020-03-05 | 2022-10-21 | 国家纳米科学中心 | 一种Mytoxin A前药及其制备方法和应用 |
| EP3909944A1 (en) * | 2020-05-14 | 2021-11-17 | Rigshospitalet | Nuclide labelled h-tetrazines and use thereof for pet and spect pretargeted imaging and radionuclide therapy |
| EP4192506A1 (en) * | 2020-08-07 | 2023-06-14 | Tambo, Inc. | Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy |
| WO2022047054A2 (en) | 2020-08-27 | 2022-03-03 | The Texas A&M University System | Inhibitors of sars cov-2 infection and uses thereof |
| US20240058455A1 (en) * | 2020-10-02 | 2024-02-22 | The General Hospital Corporation | Bioorthogonal linkers and reactions |
| WO2022197877A1 (en) | 2021-03-19 | 2022-09-22 | Genentech, Inc. | Methods and compositions for time delayed bio-orthogonal release of cytotoxic agents |
| KR20240083175A (ko) * | 2021-08-25 | 2024-06-11 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 항체-약물-접합체를 사용하는 방법 |
| US20250009890A1 (en) * | 2021-11-05 | 2025-01-09 | Tambo, Inc. | Trans-cyclooctene-modified bispecific antibodies |
| ES3039688T3 (en) * | 2021-11-25 | 2025-10-23 | Veraxa Biotech Gmbh | Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion |
| EP4372000A3 (en) | 2022-02-15 | 2024-07-17 | Tagworks Pharmaceuticals B.V. | Masked il12 protein |
| CN114652857B (zh) * | 2022-03-31 | 2023-10-20 | 成都大学 | 一种用于修复内皮糖萼受损的靶向药物递送系统及其制备方法 |
| CN115974892B (zh) * | 2022-12-27 | 2023-09-08 | 四川大学华西医院 | 三氮唑四嗪类化合物及其制备方法、应用 |
| CN116370650B (zh) * | 2023-04-14 | 2024-03-22 | 四川大学华西医院 | 基于四嗪连接子的多肽药物偶联物及其制备方法、应用 |
| CN116675664B (zh) * | 2023-04-21 | 2025-06-24 | 苏州大学 | 一种生物正交断键反应体系及前药与应用 |
| WO2025043219A1 (en) * | 2023-08-24 | 2025-02-27 | The Regents Of The University Of California | Methods for uncaging tetrazines |
| WO2025166289A1 (en) * | 2024-01-31 | 2025-08-07 | Oregon State University | Tunable tetrazine amino acids for encodable protein labeling |
| CN117700394B (zh) * | 2024-02-06 | 2024-05-28 | 南京大学 | 一类可与非张力烯基硼酸快速环加成反应的四嗪类化合物及其生物医药应用 |
| WO2025174248A1 (en) * | 2024-02-16 | 2025-08-21 | Tagworks Pharmaceuticals B.V. | Trans-cyclooctenes with "or gate" release |
| CN117752824A (zh) * | 2024-02-21 | 2024-03-26 | 中国医学科学院医学实验动物研究所 | 预靶向肿瘤免疫探针、生物正交制剂、试剂盒及应用 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826964A (en) | 1982-07-20 | 1989-05-02 | Sri International | Bridged oxygen analogs of daunorubcin and doxorubicin |
| US4486414A (en) | 1983-03-21 | 1984-12-04 | Arizona Board Of Reagents | Dolastatins A and B cell growth inhibitory substances |
| US4486444A (en) | 1983-06-20 | 1984-12-04 | Merck & Co., Inc. | (Hydroxybenzoyl)thiophenesulfonamide and acyl derivatives thereof for the topical treatment of elevated intraocular pressure |
| US4879278A (en) | 1989-05-16 | 1989-11-07 | Arizona Board Of Regents | Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15 |
| US4986988A (en) | 1989-05-18 | 1991-01-22 | Arizona Board Of Regents | Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13 |
| US5138036A (en) | 1989-11-13 | 1992-08-11 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14 |
| US5198560A (en) | 1990-04-27 | 1993-03-30 | Bristol-Myers Squibb Company | Cytotoxic bicyclo[7.3.1]tridec-4-ene-2,6-diyne compounds and process for the preparation thereof |
| US5635483A (en) | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| US6034065A (en) | 1992-12-03 | 2000-03-07 | Arizona Board Of Regents | Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10 |
| US5410024A (en) | 1993-01-21 | 1995-04-25 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide amides |
| US5780588A (en) | 1993-01-26 | 1998-07-14 | Arizona Board Of Regents | Elucidation and synthesis of selected pentapeptides |
| US5521284A (en) | 1994-08-01 | 1996-05-28 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide amides and esters |
| US5504191A (en) | 1994-08-01 | 1996-04-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide methyl esters |
| US5530097A (en) | 1994-08-01 | 1996-06-25 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory peptide amides |
| US5599902A (en) | 1994-11-10 | 1997-02-04 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Cancer inhibitory peptides |
| US5663149A (en) | 1994-12-13 | 1997-09-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| AU702976B2 (en) | 1996-05-03 | 1999-03-11 | Roger S. Cubicciotti | Prodrug compositions and drug delivery methods using synthetic receptors |
| WO1998036765A1 (en) | 1997-02-25 | 1998-08-27 | Arizona Board Of Regents | Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 |
| US6323315B1 (en) | 1999-09-10 | 2001-11-27 | Basf Aktiengesellschaft | Dolastatin peptides |
| US8236949B2 (en) * | 2007-07-17 | 2012-08-07 | University Of Delaware | Tetrazine-based bio-orthogonal coupling reagents and methods |
| WO2009109998A1 (en) | 2008-03-03 | 2009-09-11 | Lupin Limited | Novel protein tyrosine phosphatase - ib inhibitors |
| CN102271712B (zh) | 2008-10-31 | 2015-11-25 | 通用医疗公司 | 用于将物质递送至生物靶标的组合物和方法 |
| GB0906379D0 (en) * | 2009-04-14 | 2009-05-20 | Kencryst Ltd | Reduced sodium salt |
| RU2011146362A (ru) | 2009-04-16 | 2013-05-27 | Конинклейке Филипс Электроникс Н.В. | Набор для предварительного таргетинга, способ и средства, используемые в нем |
| BRPI1006246A2 (pt) | 2009-04-16 | 2020-02-04 | Koninl Philips Electronics Nv | "kit para imagem médica marcada e/ou terapias, sonda efetora e método" |
| CN103221398B (zh) | 2010-07-23 | 2016-03-23 | 特拉华大学 | 用于快速构建放射性核素标记探针的四嗪-反式环辛烯连接反应 |
| JP6063384B2 (ja) | 2010-10-14 | 2017-01-18 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | プレターゲットキット、プレターゲット方法及びその使用試薬 |
| EP2654796A1 (en) | 2010-12-21 | 2013-10-30 | Koninklijke Philips N.V. | Agents for clearing biomolecules from circulation |
| EP2522369A1 (en) * | 2011-05-09 | 2012-11-14 | Koninklijke Philips Electronics N.V. | Pretargeting kit, method and agents used therein |
| CA2836338C (en) | 2011-05-16 | 2022-05-03 | Koninklijke Philips N.V. | Tetrazine derivatives used in bio-orthogonal drug activation |
| WO2014065860A1 (en) | 2012-10-24 | 2014-05-01 | The General Hospital Corporation | Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions |
| EP4245744A3 (en) | 2012-11-22 | 2024-05-01 | Tagworks Pharmaceuticals B.V. | Chemically cleavable group |
| US20150297741A1 (en) | 2012-11-22 | 2015-10-22 | Tagworks Pharmaceuticals B.V. | Bio-orthogonal drug activation |
| WO2016025480A1 (en) | 2014-08-11 | 2016-02-18 | The General Hospital Corporation | Cyclooctenes for bioorthogonol reactions |
| WO2018004338A1 (en) | 2016-06-27 | 2018-01-04 | Tagworks Pharmaceuticals B.V. | Cleavable tetrazine used in bio-orthogonal drug activation |
| AU2019262520B2 (en) * | 2018-05-04 | 2025-07-10 | Tagworks Pharmaceuticals B.V. | Tetrazines for high click conjugation yield in vivo and high click release yield |
| DK3788032T3 (da) * | 2018-05-04 | 2024-04-15 | Tagworks Pharmaceuticals B V | Forbindelser omfattende en linker til øgning af transcyklooctenstabilitet |
| IL289095A (en) * | 2019-06-17 | 2022-02-01 | Tagworks Pharmaceuticals B V | Activating components to cleave labels from biomolecules in vivo |
| CA3143925A1 (en) * | 2019-06-17 | 2020-12-24 | Tagworks Pharmaceuticals B.V. | Compounds for fast and efficient click release |
| IL289094A (en) * | 2019-06-17 | 2022-02-01 | Tagworks Pharmaceuticals B V | Tetrazines for increasing the speed and yield of the "click release" reaction |
-
2012
- 2012-05-16 CA CA2836338A patent/CA2836338C/en active Active
- 2012-05-16 US US14/117,125 patent/US20160151505A1/en not_active Abandoned
- 2012-05-16 CN CN201810251663.9A patent/CN108524510A/zh active Pending
- 2012-05-16 CA CA2836361A patent/CA2836361C/en active Active
- 2012-05-16 WO PCT/IB2012/052445 patent/WO2012156918A1/en not_active Ceased
- 2012-05-16 AU AU2012257418A patent/AU2012257418B2/en active Active
- 2012-05-16 WO PCT/IB2012/052447 patent/WO2012156920A1/en not_active Ceased
- 2012-05-16 US US14/117,246 patent/US9421274B2/en active Active
- 2012-05-16 EP EP12725514.9A patent/EP2709666B1/en active Active
- 2012-05-16 US US14/117,655 patent/US9931408B2/en active Active
- 2012-05-16 CN CN201280035091.1A patent/CN103732257A/zh active Pending
- 2012-05-16 CN CN201280024028.8A patent/CN103732256A/zh active Pending
- 2012-05-16 EP EP21208293.7A patent/EP3973993A1/en active Pending
- 2012-05-16 ES ES12725515T patent/ES2920373T3/es active Active
- 2012-05-16 CN CN201280035096.4A patent/CN103889459B/zh active Active
- 2012-05-16 EP EP12725515.6A patent/EP2709667B1/en active Active
- 2012-05-16 DK DK12725515.6T patent/DK2709667T3/da active
- 2012-05-16 JP JP2014510928A patent/JP6215194B2/ja active Active
- 2012-05-16 CA CA2836365A patent/CA2836365C/en active Active
- 2012-05-16 AU AU2012257416A patent/AU2012257416B8/en active Active
- 2012-05-16 WO PCT/IB2012/052446 patent/WO2012156919A1/en not_active Ceased
- 2012-05-16 JP JP2014510929A patent/JP5993940B2/ja active Active
- 2012-05-16 AU AU2012257417A patent/AU2012257417B2/en active Active
- 2012-05-16 EP EP12725516.4A patent/EP2709668A1/en not_active Withdrawn
- 2012-05-16 JP JP2014510930A patent/JP6482273B2/ja active Active
-
2015
- 2015-12-30 US US14/983,858 patent/US10376594B2/en active Active
-
2016
- 2016-08-22 JP JP2016161617A patent/JP2017014262A/ja not_active Ceased
- 2016-11-23 US US15/233,283 patent/US10004810B2/en active Active
-
2018
- 2018-01-05 JP JP2018000737A patent/JP6608467B2/ja active Active
-
2019
- 2019-07-15 US US16/512,038 patent/US10967069B2/en active Active
-
2021
- 2021-02-05 US US17/169,217 patent/US11857636B2/en active Active
-
2023
- 2023-10-30 US US18/497,645 patent/US20240091371A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5993940B2 (ja) | 生体直交型薬物活性化 | |
| JP2014515040A5 (cg-RX-API-DMAC7.html) | ||
| WO2014081301A1 (en) | Bio-orthogonal drug activation |